Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
If you need a refresher on proper technique, the common peptide mistakes guide covers this and other errors in detail
AOD-9604 works gradually, producing visible changes over weeks and months rather than days
Your clinician or lab can advise whether anything should be paused before blood work
Mechanistic studies have investigated BPC-157 in the context of the VEGFR2 signaling axis and the nitric-oxide (NO) system , two pathways central to endothelial function and vascular growth
Researched applications In the published preclinical and clinical literature the effects of AOD-9604 are documented in the following areas: Obesity , Phase 2b failure (2007), but a complementary mechanism in combination protocols Lipolysis in animal models , robustly demonstrated (Heffernan 2001, Ng 2009) Inhibition of lipogenesis , demonstrated in hepatocytes and adipocytes Osteoarthritis and cartilage regeneration , emerging Phase 1/2 data (mLuna Pharmaceuticals 2018+) Tendinopathy , preclinical models Age-related sarcopenia (cachexia) , exploratory plans Lipodystrophy , preclinical data in animal models Hyperlipidemia , secondary endpoints in Phase 2 trials Science & studies 4.1 Key publications Heffernan M., Summers R.J., Thorburn A., et al
Vegans and vegetarians are at risk of B12 deficiency because its mostly found in animal products
